Fat Cell Size: Measurement Methods, Pathophysiological Origins, and Relationships With Metabolic Dysregulations
Overview
Affiliations
The obesity pandemic increasingly causes morbidity and mortality from type 2 diabetes, cardiovascular diseases and many other chronic diseases. Fat cell size (FCS) predicts numerous obesity-related complications such as lipid dysmetabolism, ectopic fat accumulation, insulin resistance, and cardiovascular disorders. Nevertheless, the scarcity of systematic literature reviews on this subject is compounded by the use of different methods by which FCS measurements are determined and reported. In this paper, we provide a systematic review of the current literature on the relationship between adipocyte hypertrophy and obesity-related glucose and lipid dysmetabolism, ectopic fat accumulation, and cardiovascular disorders. We also review the numerous mechanistic origins of adipocyte hypertrophy and its relationship with metabolic dysregulation, including changes in adipogenesis, cell senescence, collagen deposition, systemic inflammation, adipokine secretion, and energy balance. To quantify the effect of different FCS measurement methods, we performed statistical analyses across published data while controlling for body mass index, age, and sex.
Deep Learning Derived Adipocyte Size Reveals Adipocyte Hypertrophy is under Genetic Control.
Jorsboe E, Kubitz P, Honecker J, Flaccus A, Mvondo D, Raggi M medRxiv. 2025; .
PMID: 39990583 PMC: 11844614. DOI: 10.1101/2025.02.11.25322053.
Cathelicidin: Insights into Its Impact on Metabolic Syndrome and Chronic Inflammation.
Popa A, Gherasim A, Caba L, Nita O, Graur M, Mihalache L Metabolites. 2024; 14(12).
PMID: 39728453 PMC: 11676726. DOI: 10.3390/metabo14120672.
Lai X, Liu S, Miao J, Shen R, Wang Z, Zhang Z Microbiome. 2024; 12(1):223.
PMID: 39478562 PMC: 11526712. DOI: 10.1186/s40168-024-01944-4.
Targeted Nano-Based Systems for the Anti-Obesity Agent's Delivery.
Engin A, Engin E, Engin A Adv Exp Med Biol. 2024; 1460:657-676.
PMID: 39287868 DOI: 10.1007/978-3-031-63657-8_22.
c-Jun N-terminal kinase signaling in aging.
Li Y, You L, Nepovimova E, Adam V, Heger Z, Jomova K Front Aging Neurosci. 2024; 16:1453710.
PMID: 39267721 PMC: 11390425. DOI: 10.3389/fnagi.2024.1453710.